ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia (CX516)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00235352
Recruitment Status : Completed
First Posted : October 10, 2005
Last Update Posted : February 26, 2009
Sponsor:
Collaborator:
RespireRx
Information provided by:
North Suffolk Mental Health Association

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2005
  Actual Study Completion Date : February 2007